SGLT2 Inhibitors: For Heart Failure, Diabetes, and Renal Disease

Rita Jermyn

Could It Be Cushing’s? Rethinking Diabetes Management with the CATAL…

Robert Busch

Primary Aldosteronism and Implications for Primary Hypertension

Richard Auchus

The Diagnosis of Congenital Adrenal Hyperplasia Due to 21-Hydroxylas…

Mirela Miranda

Addison's Disease: The Clinical Importance of the Prepared Patient a…

John Wass

The Future of Kidney Disease (With a Nod to the Present)

Scripps Health

T. Henke

MR of the Adrenal Glands

Bones, Body and Brain MRI: Stanford Imaging Update

A. Loening

Immune Checkpoint Inhibitor Related Adrenal Toxicity in the ICU

CHEST 2022 Coverage

V. Kaul

Is Your Diabetes Out of Whack? It Could Be Hypercortisolism! | TCOYD

TCOYD

S. Edelman, D. Einhorn

Expert Guidance for Management of Adrenal and Pituitary Disorders Co…

Penn Medicine Heart and Vascular Center

D. Aizenberg, J. Kharlip, C. White, S. Panvelker

Secondary Hypertension Update: What Are the Endocrine Causes of Seco…

University of Colorado Department of Medicine

L. Fishbein

Updates in Renal Outcomes: SGLT2is and GLP-1 Agonists

Scripps Health

R. Elahimehr

Adrenal Vein Sampling

Keith Quencer

Congenital Adrenal Hyperplasia: CRF1R Antagonists

Ahmed Khattab

Surgical Considerations in Treatment of Adrenal Causes of Hypertensi…

UChicago Medicine

P. Angelos

Membranous Nephropathy: A Story to Be Told

McMaster University Department of Medicine

A. Gangji

Early Intervention and Detection of CKD: The Compelling Case for Ear…

KDIGO

V. Jha

Primary Aldosteronism Diagnosis Update: Who Should Be Screened for P…

University of Colorado Department of Medicine

L. Fishbein

Congenital Adrenal Hyperplasia: A Disorder with Systemic Ramificatio…

Icahn School of Medicine at Mount Sinai

M. Geffner

Transition Issues in CAH: Why We Need Better Treatment Up Front

Mitchell Geffner